At Global Therapeutics, we are committed to ensuring that individuals suffering from rare and high-cost diseases have access to the high-quality medications they need. We understand how important it is for them to have effective treatment, so we commit to being a reliable and dedicated partner to patients, patient organizations, healthcare providers, payers, and institutions. We seek to improve the quality of life for all those who require such medications and thereby contribute to the health and well-being of society.
Our purpose
To provide access to high-quality medicines for orphan diseases, which would otherwise not be available in the local market. To this end, we focus our efforts on being a committed and reliable partner that contributes to improving the health status, quality of life, and well-being of patients, members of the insurance system, and treating physicians.
Our objective
To be recognized as a company that enables access to new health technologies for orphan diseases, high-cost conditions, and those requiring medications not available in the local market, ensuring high quality standards. We are characterized by being a committed and reliable partner for payers and health service providers, seeking to guarantee the quality of life and well-being of patients suffering from these types of diseases.
Values
1.
COMMITMENT
We are committed to providing access to medications for the treatment of orphan diseases, supporting patients and their families in their fight against these conditions.
2.
EXCELLENCE
We strive to maintain high standards of quality in all our processes and services, ensuring the delivery of safe and effective medications.
3.
INTEGRATION
We value the integration of different perspectives and work in collaboration with patients, health professionals to achieve a positive impact.
4.
BOLDNESS
We dare to seek innovative solutions and face challenges to provide treatment options to people affected by orphan diseases, through access to high-quality medications.
5.
TEAMWORK
Strategic purpose
For 2024, we will continue to focus our commitment and effort on being a leading ally in providing access to high-quality medications for the treatment of respiratory orphan diseases, inborn errors of metabolism, behavioral disorders, renal involvement, and autoimmune diseases; aiming to ensure the quality of life and well-being of patients and position our market participation.
Quality objectives
1.
Increase customer satisfaction.
2.
Continuously improve our processes.
3.
Ensure timely delivery.
4.
Ensure product quality.
5.
Comply with applicable legal and contractual requirements.
6.
Improve the performance of our employees.
Experience
We have a team of top-tier executives with over 25 years of experience in entrepreneurship and who have worked in companies in the Pharmaceutical market, Insurance companies (EPS), and Health Service Provider Institutions (IPS).
Institutions of Interest
